Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP713032.RAKBKnyR0wX8PsCZzhPY4pi8yl9CEjaOibYBWqYrJhpJg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP713032.RAKBKnyR0wX8PsCZzhPY4pi8yl9CEjaOibYBWqYrJhpJg130_assertion type Assertion NP713032.RAKBKnyR0wX8PsCZzhPY4pi8yl9CEjaOibYBWqYrJhpJg130_head.
- NP713032.RAKBKnyR0wX8PsCZzhPY4pi8yl9CEjaOibYBWqYrJhpJg130_assertion wasGeneratedBy ECO_0000203 NP713032.RAKBKnyR0wX8PsCZzhPY4pi8yl9CEjaOibYBWqYrJhpJg130_provenance.
- NP713032.RAKBKnyR0wX8PsCZzhPY4pi8yl9CEjaOibYBWqYrJhpJg130_assertion wasDerivedFrom befree-20150227 NP713032.RAKBKnyR0wX8PsCZzhPY4pi8yl9CEjaOibYBWqYrJhpJg130_provenance.
- NP713032.RAKBKnyR0wX8PsCZzhPY4pi8yl9CEjaOibYBWqYrJhpJg130_assertion SIO_000772 22784038 NP713032.RAKBKnyR0wX8PsCZzhPY4pi8yl9CEjaOibYBWqYrJhpJg130_provenance.
- NP713032.RAKBKnyR0wX8PsCZzhPY4pi8yl9CEjaOibYBWqYrJhpJg130_assertion evidence source_evidence_literature NP713032.RAKBKnyR0wX8PsCZzhPY4pi8yl9CEjaOibYBWqYrJhpJg130_provenance.
- NP713032.RAKBKnyR0wX8PsCZzhPY4pi8yl9CEjaOibYBWqYrJhpJg130_assertion description "[The TDF-FTC group had higher rates of nausea (18.5% vs. 7.1%, P<0.001), vomiting (11.3% vs. 7.1%, P=0.008), and dizziness (15.1% vs. 11.0%, P=0.03) than the placebo group, but the rates of serious adverse events were similar (P=0.90).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP713032.RAKBKnyR0wX8PsCZzhPY4pi8yl9CEjaOibYBWqYrJhpJg130_provenance.